The Rising Tide of Heart Disease in People Living with HIV
For decades, HIV has been a global health challenge. Yet, as advancements in antiretroviral therapy (ART) extend lifespans for those living with the virus, a new concern is gaining prominence: cardiovascular disease (CVD). What was once considered a secondary issue is now recognized as a leading cause of morbidity and mortality within the HIV-positive population.
Why the Increased Risk? Unpacking the Connection
People living with HIV (PLWH) experience a significantly higher risk of developing various forms of CVD, including myocardial infarction (heart attack), heart failure, stroke, and pulmonary hypertension. This isn’t simply a consequence of aging; unique factors related to HIV infection and its treatment contribute to this increased vulnerability. The key appears to lie in persistent immune activation and inflammation, even in individuals with suppressed viral loads thanks to ART.

Recent research highlights the role of chronic inflammation in accelerating atherosclerotic cardiovascular disease (ASCVD) in PLWH. Markers of inflammation, such as IL-6 and C-reactive protein, are often elevated and can predict mortality in this population. Emerging insights point to mechanisms like clonal hematopoiesis and trained immunity as potential drivers of this ongoing inflammation.
The Role of Inflammation and Immune Dysregulation
Even with effective ART, the immune response in PLWH remains persistently dysregulated. This ongoing immune activation contributes to a state of chronic inflammation, which damages blood vessels and promotes the development of atherosclerosis – the buildup of plaque in the arteries. This process is further complicated by potential effects on lipid metabolism and other cardiovascular risk factors.
The concept of “trained immunity” is gaining traction. This refers to a long-lasting alteration in immune cell function following an initial stimulus. In the context of HIV, it’s theorized that prior exposure to the virus, even if controlled by ART, can “train” the immune system to overreact to other stimuli, exacerbating inflammation.
Advances in Diagnosis and Treatment
Fortunately, advancements in cardiac imaging modalities are improving our ability to detect and assess CVD in PLWH. These tools allow for earlier diagnosis and more targeted interventions. However, managing CVD in this population requires a holistic approach that addresses both traditional risk factors (like high blood pressure and cholesterol) and HIV-specific considerations.
Current research is exploring novel therapeutic strategies to address the underlying inflammation driving CVD in PLWH. This includes investigating interventions that target specific inflammatory pathways and modulate the immune response.
Future Trends and What to Expect
The future of HIV and CVD management will likely focus on several key areas:
- Personalized Medicine: Tailoring treatment strategies based on individual risk profiles, inflammatory markers, and genetic predispositions.
- Inflammation-Targeted Therapies: Developing and testing new drugs specifically designed to reduce chronic inflammation in PLWH.
- Improved Screening Protocols: Implementing more comprehensive and routine cardiovascular screenings for all individuals living with HIV.
- Focus on Comorbidities: Addressing other health conditions that contribute to CVD risk, such as diabetes and kidney disease.
FAQ
Q: Is cardiovascular disease inevitable if I have HIV?
A: No. While the risk is increased, proactive management of your health, including ART adherence, lifestyle modifications, and regular screenings, can significantly reduce your risk.
Q: What lifestyle changes can I make to protect my heart?
A: A heart-healthy diet, regular exercise, maintaining a healthy weight, and avoiding smoking are all important steps.
Q: How often should I get my heart checked if I have HIV?
A: Discuss a screening schedule with your healthcare provider. The frequency will depend on your individual risk factors.
If you are living with HIV, staying informed and proactive about your cardiovascular health is more important than ever. Talk to your doctor about your individual risk factors and develop a plan to protect your heart.
Explore further: Learn more about HIV and related health topics at HIV.gov.



